Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV002449637 | SCV002683316 | likely benign | Cardiovascular phenotype | 2018-09-17 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Color Diagnostics, |
RCV003581848 | SCV004358048 | likely benign | Familial hypercholesterolemia | 2023-02-15 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV003776523 | SCV004675399 | likely benign | Hypercholesterolemia, autosomal dominant, 3 | 2023-02-24 | criteria provided, single submitter | clinical testing | |
GENin |
RCV003581848 | SCV005441500 | likely benign | Familial hypercholesterolemia | 2024-05-28 | criteria provided, single submitter | clinical testing | This is a synonymous (silent) variant that is not predicted by SpliceAI to impact splicing. In addition, it occurs at a nucleotide that is not conserved. Therefore this variant has been classified as Likely Benign (BP4, BP7). |